OPRX

OptimizeRx Corporation Common Stock

OPRX
Closed
$6.31
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 104 full-time employees. The company went IPO on 2005-05-18. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
Country

US

CEO

Mr. Stephen Silvestro

IPO date

2005

Employees

133

ISIN

US68401U2042

Key stats

Open

$6.28

Volume

463.38K

Market cap

$117.84M

Prev. close

$6.28

Impl / hst vl

-

Open interest

$0.00

$6.24

Day’s Range

$6.45

$4.54

52W Range

$14.16

Valuation

61
Valuation score
Undervalued
P/E
17.31
P/S
1.10
P/B
0.91
Current ratio
5.37
Debt / Equity
0.02
ROE
5.47%
Gross margin
75.25%
Income growth
-109.86%
FCF growth
-106.69

Analysts estimates

Consensus rating
Buy

The average rating from top 7 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$12.65
The top 7 analysts forecasts that 12-month price may increase by 100.44%, with a low of $9.09 and a high of $18.90
$9.09
Low
$12.65
Avg
$18.90
High
Current price

Earnings

Q1 ‘26 revenue
$19.84M
Q1 ‘26 net income
-$495.00K
Revenue
Net income
Previous EPS
$0.14
Estimate EPS
$0.12
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply